CD40LG and COVID-19: Heinz et al. found that TRAP or arachidonic acid did not influence platelet aggregability in COVID-19 patients compared to healthy subjects, whereas it was reduced by ADP treatment; however, they concluded that their results were limited by the small group size [65].